Concepedia

Joerg Koglin

JK

Statistics

Publications

36

Citations

7.9K

H-Index

26

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Boston Scientific (United States)

Clinical Research Institute

University of Alberta

Canadian VIGOUR Centre

Joerg Koglin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cardiovascular disease, and cardiology.

ORCID

Top concepts

Publications per year

1998–2025

36

Publications

36

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong et al. · New England Journal of Medicine · 2015 · 2.5K citations · Full text

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Paul W. Armstrong, Burkert Pieske, Kevin J. Anstrom et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease

Gregg W. Stone, Stephen G. Ellis, Louis Cannon et al. · JAMA · 2005 · 764 citations

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

Marius M. Hoeper, David B. Badesch, Hossein Ardeschir Ghofrani et al. · New England Journal of Medicine · 2023 · 557 citations · Full text

The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase

Andrew T.L. Ong, Patrick W. Serruys, Frederick W. Mohr et al. · American Heart Journal · 2006 · 336 citations

, , +9

Rows per page

1–5 of 36